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Purpose or Objective: Brain tumours as many other 
neurological diseases may cause sleep problems interfering 
with the delicate mechanisms of sleep regulation. The 
presence of a disturbed sleep may have material daily 
performance effects. In growing subjects this aspect may 
determine emotional and behavioral problems. The 
prevalence of sleep disorders (SD) in children with brain 
tumours is unknown. The main aim of this study is to 
compare the prevalence of SD in children affected by brain 
tumours and treated with radiotherapy to the prevalence of 
SD in children treated only surgically. 
 
Material and Methods: A retrospective case-control study 
was performed from October 2014 to April 2015 in a Pediatric 
Department and in a Pediatric Radiotherapy Centre. "Cases" 
included patients 2 to16 years old with a diagnosis of CNS 
tumour at least 3 months after treatment conclusion (surgery 
and radiotherapy and/or chemotherapy). "Controls" were 
children 2 to 16 years old with CNS tumours treated only 
surgically. Children’s sleep quality was assessed with a 
questionnaire administered to parents (Child's Sleep Habits 
Questionnaire, CSHQ). The sleep was considered disturbed if 
at least one of the following events was present: sleep delay, 
sleep duration, sleep-related anxiety, night waking, 
parasomnias and respiratory disorders. The risk of SD was 
estimated by the Odds Ratio (OR) and their 95% confidence 
intervals (95% CI) through logistic regression models. 
 
Results: We enrolled 14 cases and 14 controls, for a total of 
28 subjects. 9 out of 14 children in “case” group were 
treated with surgery, radiotherapy and chemotherapy. Our 
results highlighted a prevalence of SD of 57.4% among cases 
and 42.9% in controls. A statistically significant difference 
between the two groups (OR= 1.78 CI: 0.40-7.94) was not 
reached. 
 
Conclusion: Cranial irradiation is required to treat many 
brain tumours in children. Some studies involving only 
children with midline tumours show that high-dose cranial 
irradiation in midline site in childhood is associated to 
objective and subjective changes in the sleep-wake rhythm in 
adulthood. Our study failed to show a statistically significant 
difference in SD between the two groups, but there is 
evidence of a greater prevalence among children treated 
with radiotherapy. Limitations of the study include the small 
number of patients involved and the lack of irradiation 
details, as dose and site. We expect that a relationship 
between cranial irradiation and SD will be statistically 
confirmed increasing the number of involved patients. We 
hope to better define the relationship with irradiation dose 
and site, as brain tumour position and consequent irradiation 
may have a role on SD development. 
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Purpose or Objective: The aim of the study is to evaluated 
data from radiosurgery (RS) and fractionated stereotactic 
radiotherapy (FSRT) performed in patients from 0 to 14 years 
of age in Hospital Araújo Jorge, Goiânia, Goiás, Brazil, 
treated between 2000 to 2013. 
 
Material and Methods: The authors retrospectively assessed 
medical reports of 65 patients from 0 to 14 years of age with 
diagnosis of brain tumors and who underwent RS/FSRT from 
2000 to 2013. The analysis concerns age at diagnosis, primary 
location of the tumor, size of the tumor, risk assessment, and 
employment of either RS or FSRT. 
 
Results: From the 65 records, 42 were included in the 
analysis for having all the information desired. Of those 
patients, 46.3% were male and 69.0% were diagnosed with 
malignant tumors. 29.3% of the patients were between 0 to 6 
years, 31.7% between 7 to 10 years, and 39.0% between 11 to 
14 years of age. The most frequent histophatological 
diagnoses were medulloblastoma (19.0%), arteriovenous 
malformation (14.3%), and glioma (11.9%). As for the 
treatment, 78.5% underwent to FSRT and 21.5% underwent to 
RS. The median total radiation dose prescribed dose was 
54Gy for the FSRT and 18Gy for the RS. The most frequent 
prescription dose curves were 90% and 95%, respectively, 
whilst the conformity index for the RS varied from 1.23 to 
2.04. It resulted in 42.9% of the patients having partial 
response to the performed treatment and 78.6% not having 
distant disease progression. The overall survival was 58.1 
months for patients from 0 to 6 years, 69.3 months for those 
from 7 to 10 years, and 90.2 months for those in the 11 to 15 
years range (p=.0037). 
 
Conclusion: The results show a 13 years experience on 
treating pediatric tumors with RS/FSRT of that single 
institution. High precision conformal stereotactic techniques 
with RS/FSRT employing conservative margins than 
conventional radiotherapy in childhood tumors appears to be 
safe based on our experience. Long term prospective trials 
are required to test their real potential in sustaining local 




ANDANTE: second cancers from neutrons following proton 
therapy: preliminary epidemiological results 
K. Perstorfer
1Bundesamt für Strahlenschutz Federal Office for Radiation 
Protection, AG-SG 1.3, Neuherberg, Germany 
1, L. Walsh1 
 
Purpose or Objective: Survivors of childhood cancer 
generally have an increased risk of developing secondary 
cancers associated with the treatment for the first primary 
cancer. Proton therapy represents a highly effective 
treatment technique for some types of childhood cancers but 
scattered radiation from secondary neutrons is an unwanted 
by-product. 
 
Material and Methods: The ANDANTE project investigates the 
relative risk of neutrons compared to photons for 
tumorigenesis, as a function of dose and energy. The 
approach is multidisciplinary, including physical 
measurements and modeling, molecular biology, radiobiology 
and epidemiology. Based on stem cells irradiated in vitro 
with either photons or neutrons, a corresponding predicted 
model of the relative risk of cancer induction from photons or 
neutrons following pediatric radiotherapy is developed and 
tested on clinical data, leading to a proposal for a 
prospective epidemiological study to validate the relative risk 
of neutrons on the tumorigenesis in humans. The progress on 
the epidemiological aspects of this current work is reported 
here. 
 
Results: In order to validate the dose-risk model developed 
earlier in the project, a feasibility study with clinical data 
from the Loma Linda University Medical Centre (LLUMC) was 
performed. A cohort of 242 patients was constituted in 
August 2013. Those patients were treated between 1991 and 
2013, diagnosed with arteriovenous malformation (AVM) 
(n=108) or low grade astrocytoma (n=134) before the ages of 
30 years, and were followed up later. All variables for 
statistical analyses are available but data extraction has not 
been finished yet. Results of this feasibility study will provide 
a basis for the development of the prospective 
